Post-market Review of the use of biologics in the treatment of severe chronic plaque psoriasis

The Pharmaceutical Benefits Advisory Committee (PBAC) Minutes pertaining to the Draft Review Report for the Post-market Review of the use of biologics in the treatment of severe chronic plaque psoriasis are now available on the Review web page.